Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers

Summary

This is a first-in-human, Phase I, single-dose escalation and multiple-dose escalation clinical trial for FTP-198 conducted in Australian healthy volunteers. The safety, tolerability, and pharmacokinetics of FTP-198 suspension in healthy volunteers will be evaluated using a randomized, double-blind, placebo-controlled trial design.

Timeline

Start

2020-02-24

Primary completion

2020-11-05

Completion

2020-11-05

Drugs

Indications

No indication recorded.